BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35656850)

  • 21. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
    Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
    JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early switch from intravenous to oral antibiotic treatment in bone and joint infections.
    Sendi P; Lora-Tamayo J; Cortes-Penfield NW; Uçkay I
    Clin Microbiol Infect; 2023 Sep; 29(9):1133-1138. PubMed ID: 37182643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
    Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
    BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.
    Paladino JA; Sperry HE; Backes JM; Gelber JA; Serrianne DJ; Cumbo TJ; Schentag JJ
    Am J Med; 1991 Nov; 91(5):462-70. PubMed ID: 1951408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
    Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
    Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia.
    Rosen AB; Fowler VG; Corey GR; Downs SM; Biddle AK; Li J; Jollis JG
    Ann Intern Med; 1999 May; 130(10):810-20. PubMed ID: 10366370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of complex bone and joint infections in France using a national registry: The CRIOAc network.
    Lemaignen A; Bernard L; Marmor S; Ferry T; Grammatico-Guillon L; Astagneau P;
    J Infect; 2021 Feb; 82(2):199-206. PubMed ID: 33352213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From 'OPAT' to 'COpAT': implications of the OVIVA study for ambulatory management of bone and joint infection.
    Seaton RA; Ritchie ND; Robb F; Stewart L; White B; Vallance C
    J Antimicrob Chemother; 2019 Aug; 74(8):2119-2121. PubMed ID: 30989175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.
    Nathwani D; Eckmann C; Lawson W; Stephens JM; Macahilig C; Solem CT; Simoneau D; Chambers R; Li JZ; Haider S
    Clin Microbiol Infect; 2014 Oct; 20(10):993-1000. PubMed ID: 24673973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial.
    McMeekin N; Geue C; Briggs A; Rombach I; Li HK; Bejon P; McNally M; Atkins BL; Ferguson J; Scarborough M;
    Wellcome Open Res; 2019; 4():108. PubMed ID: 31930174
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema.
    Stockmann C; Ampofo K; Pavia AT; Byington CL; Sheng X; Greene TH; Korgenski EK; Hersh AL
    Hosp Pediatr; 2015 Dec; 5(12):605-12. PubMed ID: 26526596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
    Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
    Trials; 2018 May; 19(1):297. PubMed ID: 29843781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prosthetic joint infections due to Staphylococcus aureus and coagulase-negative staphylococci.
    Tornero E; García-Oltra E; García-Ramiro S; Martínez-Pastor JC; Bosch J; Climent C; Morata L; Camacho P; Mensa J; Soriano A
    Int J Artif Organs; 2012 Oct; 35(10):884-92. PubMed ID: 23138701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
    Cervera C; Sanroma P; González-Ramallo V; García de la María C; Sanclemente G; Sopena N; Pajarón M; Segado A; Mirón M; Antón F; Basterretxea A; Cuende A; Miró JM;
    Infect Dis (Lond); 2017 Mar; 49(3):200-207. PubMed ID: 27820968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facing multidrug-resistant pathogens in periprosthetic joint infections with self-administered outpatient parenteral antimicrobial therapy-A prospective cohort study.
    Frieler S; Hanusrichter Y; Bellova P; Geßmann J; Schildhauer TA; Baecker H
    J Orthop Res; 2021 Feb; 39(2):320-332. PubMed ID: 33174643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient parenteral antibiotic therapy for the treatment of prosthetic knee and hip infections in Belgium, a cost minimization analysis.
    Debaenst N; Seyler L; Putman K; Van Den Borre I; Vanlauwe J
    Acta Clin Belg; 2022 Feb; 77(1):10-17. PubMed ID: 32484406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis.
    Iversen K; Ihlemann N; Gill SU; Madsen T; Elming H; Jensen KT; Bruun NE; Høfsten DE; Fursted K; Christensen JJ; Schultz M; Klein CF; Fosbøll EL; Rosenvinge F; Schønheyder HC; Køber L; Torp-Pedersen C; Helweg-Larsen J; Tønder N; Moser C; Bundgaard H
    N Engl J Med; 2019 Jan; 380(5):415-424. PubMed ID: 30152252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Retrospective Analysis of Intravenous vs Oral Antibiotic Step-Down Therapy for the Treatment of Uncomplicated Streptococcal Bloodstream Infections.
    Ramos-Otero GP; Sarangarm P; Walraven C
    J Clin Pharmacol; 2022 Nov; 62(11):1372-1378. PubMed ID: 35661173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.